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Abstract
Objectives: The study of clinical features,diagnostic meth-
ods and prognosticfactors of bacterial meningitis, in an ur-
banarea.
Patients and Methods: All patientsadmittedbetweenJune
2001andJuly 2004in the emergencydepartmentsof a few














serotypesarenot includedin anyof theavailablevaccines.
Eighteenpatientsdied (8.9%). Thestatisticanalysisfound
thatfactorsassociatedwithanadverseoutcomewereageolder
than50 years(aR 7.07; IC 95%1.1-27.4), the presenceof
comorbidities(aR 3.3; IC 95%1.1-9.6) andthe occurrenceof
systemiccomplications(aR 5.8; IC 95%2.1-16.0).
Conclusions: This epidemiologicpatternis similar to that
foundin othercountriesafterthe introduction of Haemo-
philus influenzaeb conjugatedvaccine.The associationof
cultureandnonculturalmethodsof diagnosishada better
performancein definingthe etiology. Comparingto other
series,in-patients mortalityratewaslower(8.9%) than
usuallyreferredto, beingconsideredunfavourableprognos-





Bactcrialmeningitisis still associatedwith highmortality
and neurologicalsequelae,evenin developedcountries.
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The severeformsof thisdiseasearea medicalemergency
that can dramaticallydeteriorate to a severe form of
intracranialhypertension,with consciousnessdepression
or neurologicaldeficits[1,2]. While Streptococcuspneu-
moniae meningitisoceurs in ali age groups, Neisseria
meningitidisis the first causeof meningitisin ehildren,
althoughit canalso affectother agegroups[3,4].
Importantmodifieationsin the etiologyof bacterial
meningitis have been observed in the last deeades,
resultingfrom the developmentand availability of the
new eonjugatedvaeeines,designedafter the antigenic
definitionof the mostcommonetiologieagents:Haemo-




diagnosis,as the caseof molecularbiology techniques,
including real time PCR, which has a sensitivityand a
specificityhigherthan90% [8,9].
Another importantpoint wasthe emergenceof anti-
biotic-resistant meningeal pathogens, particularly S.
pneumoniae,with the increaseof fJ-lactam multi-drug
resistantisolates,althoughwith a different geographic
distribution.This is a growing problem in Europe that
should not be forgottenwhen empirictreatmentof bac-
terialmeningitisis administeredandenhancestheneedof
a correctetiologicaldiagnosisaswell asa correetknowl-
edgeof local susceptibilityprofile to antibiotics[10,11].
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As far as prevention is concerned, some advances
during the last few years have to be acknowledged, with
the introduction of conjugateel vaccines against the most
common agents. Epidemics by N. mcninf.;itidis01' sero-
group C has led to the introduction 01' the conjugateel
vaccine in the national immunization programs 01' several
European countries [12, 131.Recent publications of sur-
veillance studies 01' meningococcal disease demonstrate
the efficiency after 4 years 01' use of the conjugated vac-
cine in those countries, with a reduction in serogroup C
incidence anela stable incidence of disease caused by se-
rogroup B [14, 15]. Concerning pneumococcal disease
prevention, some improvements have also been achieved,
with the development of the conjugated vaccines [161.In
addition to their cfficacy in preventing invasive disease,
these conjugateel vaccines also reduce the rate 01' naso-
pharyngeal carriage in chilelren and could have the po-
tential to decrease the transmission to non-immunizeel
persons [17,18]. Moreover, as antibiotic resistanceis more
commonly associated with the vaccine serotypes, vacci-
nation can also have an impact on the emergence 01'
resistant pneumococcal infections [14, 19].
ln Portugal the conjugated vaccine to H. injfucnzac
b has been included in the national immunization
programme in 2000 and the conjugated vaccine to
N. mcningitidisserogroup C has been introduced in
January of 2006. The heptavalent conjugateel pneumo-
coccal vaccine is commercially available in Portugal but
has not been inclueled in the immunization programme
yet, although it is frequently prescribed, and stuelies to
evaluate its eff1cacyare under way.
Our aim is the study 01' clinical presentation, diag-
nostic methods and prognostic factors 01' bacterial men-
ingitis in an urban arca.
Patients, Materiais and Methods
rrom June 2001 to July 2004.201 patients admitted in the
emergeneydepartmenlsof the Oporlo metropolitanarea with
diagnosisof aculemeningitiswereselectedfor study.
The cohorl inclueledchildrenanelaelultswith agesranging
from 1month to 82yearsof age (averageage 26 years).One
hundreelaneltwenly(60%) patientsweremales.
Diagnosis of meningitiswas based on an acute clinical
synelromewilh a lessthan a week'sevolution,confirmedby a
lumbar tapoBacterialactio]ogywas consideredwhen CSF cy-
losis exceeeled1.000leukocytes/~tlwith proleins values higher
lhan 50mg/dlandglucoselower than50% of blood valuesandl
or if CSF cylosis lowcr Ihan l,OOObut greater than 6 leuko-
cyles/pl in the presenceof a quiek eXlendingpurpurieand/or
pelechialexantem.Ali CSF andblood specimenswerecultured
by microbiologicalstandardmcthoelsand some sampleswere
tesled for capsularantigens.A csr aliquol from the same
samplecollectedfor initial eliagnosiswas storeelat -70°C for
subsequentsludy.
The se!cclionof patientswasdonein emergeneydepartment
andafter lhis,patients'clinicalandanalytiedatawerecolleeted
hasedon medicalrecordsduringhospitalization.
Infection 35 . 2007 . No. 6 © URBAN & VOGEl
L.c. Santos et aI. Bacterial Meningitis in an Urban Area
A definitivediagnosisof baeterialmeningitiswasbaseeion
agentidentificalionfrom csr and/orhlooelcultureby standard
melhods,latexagglutinationor by a PCR assay.Caseswith a
negativemicrobiologicinvestigation,butCSF leucoeytes> 1.0001
plwereconsideredasprobablecasesandalsoincludedinthestudy.
A PCR assaywas applied to 86 CSF samples.46 culture
posiliveanel40 csr culturenegativespecimens.The 36culture-
confirmedsamples,for lhe threemore cOlllmonagentsof bac-
terial Illeningilis inclueleelS. plleulllolliae [20J. N. lIlellillgitidi.l'
[13],andH. illfluetlzue[3J. Olher len culture-positiveCSF sam-
pIes for Staphy/ococcu.l'epiderlllidis.Sa/lllonella spp.. Entero-
bacterspp.. Enterucuccusspp.and K/eb.l'iellaspp.wereincluded
10 lesl specificity.
The PCR assaywascarrieelout usingthe primerssetsof a
real time PCR Illelhod as eleseribedby Corless: p/y for S.
ptleulllolliae,ctrA for N. lIIenitlgitidisandbexA for fi. illfluenzae
[20]in culture-negativeandculture-positivesalllp!cs.Syhergreen
delectionwas usedinsteadof speeificN. lIleningitidi.l'.S. pneu-
lIloniae and H. influenzaeprobesand ampliconspecificityveri-
fied with meltingcurveanalysis.
Nei.l'.I'erialIleningitidisATCC 13090,S. pneullloniaeATCC
49619and a clinical isolate of H. influenzueb were used as
controlstrains.The bacterialsuspensionsweretestedandusedas
posilivecontrol in eachrun.
In culture-positivecases,the isolateswerestoredat -70°C
in Brain-J-IeartIlledium aeldedwith 20% glycerol for antigenic
characterizalion,usingcOlllmerciallyavailableantisera(Staten.l'
Serulll/nstitut- Copellhague).Susceptibilitiesto the anlibiotics
commonly used were delerminedaccordingto lhe "National
Committee for Clinical Laboratory Stanelards" (NCCLSS)
guidelinescriteria [21J.





Crude OR anel,respectively,95% confielenceintervals(95%CI)
were useelto measurethe associationbetweenseveralfactors
anelthe likelihood of an unfavorableoutcome.Logistic regres-
sion wasuseto eslimateerudeORo For statisticalanalysesSPSS
12.0wasuseel.
Results
ln this 3-year period bacterial meningitis was diagnosed in
201 patients. ln 88 (43%) patients, at least one comor-
bidity was present: previous neurosurgery anelpneumonia
in 28 (14%) patients each, head trauma in 23 (li 0!c,).
cerebrospinal leakage in 22 (11%), suppressed immune
system conelition in 19 (9%), diabetes in 17 (8%), acute
otitis in 14 (7%), alcoholism in 10 (5%), ventriculoperi-
toneal shunt in 9 (4%), chronic otitis in 8 (4%), sinusitis in
7 (3%), cardiac failure in 6 (3%), splenectomy, drug abuse
anelchronic renal failure in two patients each and Celiac
disease, Cushing syndrome, congenital heart disease in
one patient each; in 32 (15.4%) antibiotics hael been
prescribed before admission. Meningitis was recurrent in
17 of the patients (8.4%).
Clinical findings observed on admission, by agegroup,
are elisplayeelin table 1. ln 97 (48%) patients some form
01' neurological or/and systemic complication occurreel
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Table 1
Clinical findings at admission by age group.
S; 5 years






45 2122 61, 36
Altered mental status
6369 87040
(GCS < 15) Nuchal rigidity
4c72 732
B havior manifestations




















73 (36)8 (4 40 (20)01
aGrunting in 8 infants; bNot applicable in 29 pts; cBulbing fontanelle in 3 neonates and in other 9infants (12); dNotapplicable in 45 pts; "Not applicable in 31 pts
Table 2
Etiologic diagnosis of bacterial meningitis and method of
detection.











positivein ali culture-conflrmedsamplesfor S. pncllmo-
niac(100%)andfor N. meningitidis(100%).In twoof the
threecasesof H. infillcnzacthe methodfailed thisagent
detection.PCR wasnegativein ali sampleswitha positive
cultureto other agents.
PCR hasallowedthe identificationof N. meningitidis
in 17CSF culture-negativesamplesandof S. pnclllnoniac
in other 16.The PCR to H. infillcnzaewasnegativein ali
theseassays.In sevensamplesno agentwasidentifiedby
PCR assay.In one of them[atexagglutinationwasposi-
tive for N. meningitidis.[n two casesthe diagnosiswas
based exclusivelyin a positive latex agglutinationtest
result:I-I. inflllenzaeand N. meningitidisin one each.In
summary,an etiologicdiagnosiscould be estab[ishedin
177(88%) cases,by culturemethodsin 142casesandby
nonculturemethodsin 35 cases(Table 2). In 24 (12%)
patientsthe aetiologycould not be determinedincluding
the six sampleswith a negativePCR assay. [n those










Coma Scale < 15) in 170
(R5%) patients,the score
beinglessthan 10(GCS 3-
10) in 77 (37%) anelbe-
tween 1i and 14 in 93
(45'}\».A normal mental
statllswas observedin IR
(9%) patients;for 13 pa-
tients no informationwas
registereel. Seizurcs oc-






were observeelin 55 pa-
tients, with mlllti-organ
elysfllnctionin34(17%):33
(17°;\»had hypotensionwith shock in 27 (13%), coagll-
lation elisordersin 37 (IR%), respiratoryfailurc in 29
(14%) and aCllterenal failure in 20 (10%) cases.Hem-
orrhagicrashwasobservedin49(24%). One hllnelredand
one (50%) patientsreqllireelaelmissionto the intensive
carc lInit with 39(19%) needingrcspiratorysupport.
The CSF studyshoweelthatcytosisvariedfrom 10to
31 360cclls/~tl(4,631± 5,736),glucosefrom Omg/dl to
272mg/dl (40±37), and proteins from 10mg/dl
to 20,000mg/dl(56R±2,291).
BacteriologicResults
The Gram-stain,performedin only 64 CSF samples,was
positivein 22 (33%). The latex aggllltinationtest, per-
formedin 103of the CSF samples,was positive in 65
(63.1%), while idcntifyingN. meningitidisin 41,S. pnell-
moniaein21anelH. inflllenzaein 3.Culture ielentification
wassuccessfulin 142patients(70.6%):S.pnellmoniaein55,
N. meningitidisin51andotheragentsin36,including4 out
of the 5 casesof H. injlllenzaemeningitis:the other 32
agentsielentifiedbyculturalmethodswere:StaphylococclIs
spp. [131, Klcbsiclla spp. [3], Pselldomonasspp. [3],
Strcptococellsagalaetiae[21,Streptococellsviridans[2], Entero-
lmeterspp. [2], StreptococclIspyogenes[I], EnterococClls
Jaecillm [IJ, lIacmophilllsparainJlIenzac[I], E. eoli [I],
Salmonellaspp.[I], Brueellaspp.[1]andListeriamonoeytog-
enes[I]. [n59cases(29.4%)noagentwasidentifiedbyculture.
CSF PCR assaywas appliedto 86 samples,40 with
culture negativesamplcsand 46 CSF specimenswith
culture-confirmcddiagnosis.In culture-confirmeelcases,
PCR assaywasdone in CSF samplesof S. pnellmoniae
[20],N. meningitidis[13],andotheragents[13]including3
isolatesof 11.inflllcnzae.PCR DNA amplificationwas
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apresentin PPV23;bpresentin 7V-PnCandin 9V-PnC;cPresentin llV-PnC;dNotcontainedin thePPV23norin anyof theconjugatedvaccines
purulent in ali of them, with a cytosis varying fram 2,100
to 1O,RROcells/~d(3,545 ± 1,71R).
The sensitivity of culture methods was 55.6%
(IC 95%: 47.7-55.6) anel 43.3% (IC 95%: 34.4-43.3),
respectivcly, for S. pnclImoniacand N. mcningitidis,with a
specificity of 100% (IC 95%: 95-1(0). For the same
agents, the sensitivity of PCR compared to cuIture was
100% (IC 95%: 85.9-I()O), with a speciticity of n.R%and
78.5%, respectivcly.
Ali the patients received antibiotic therapy. Dexa-
methasone had been administered in 87 cases (42%), for
4 days. 11 was prescribed in 36 (51°;',) or the cases of
S. pncllmoniacmeningitis, in 2R (41%) of the N. mcnin-
gitidismeningitis and in the two casesof 1/. injiucnzacthat
occurred in children, in other 12 cases with no agent
identified and in 9 cases with other identitied agents.
The antigenic characterization of the N. mcningitidis
strains is given in table 2. The most common antigenic
combination of serogroup C was "C:2b:PI.5,2" and
"C:2b:PI.2,5. For serogroup B the serotype and subtype
combinations were diverse, serotype 4 being the most
frequent and serotype 2a being found in two strains.
Serotype C:2b was present in 87% of the strains. No sero-
types C: 2a were found (Tablc 3).
Characterization of S. pncllflloniac serotypes was
successful only in 32 (58%) cases. Identifieel serotypes,
their distribution by age group and inclusion in the
available vaccines are in the table 4.
Antibiotic susceptibility tests revealed that six (lI %)
isolatesor S.pncumoniacwere resistant to penicillin, three
(14, 19A, 19A) had intermediate resistance (MIC ~ I pg/
ml) and other three (14, 19A, 23F) were highly resistant
(MIC ~2 pg/ml); four iso-
lates (14, 23F and two 19A)
were in addition resistantto
ccfotaxime (MIC ~ 1-2 pg/
ml) and one (23F) to levo-
ftoxacin (MIC ~ 16 pg/ml).
The six patients in-
fected with pneumococcal
strains with high 01' inter-
mediate grade resistance to
penicillin recovered; three
were treated with ceftriax-
one and vancornycin, two
with ceftriaxone and ampi-
cillin and the remaining
one with ceftriaxone.
Ali the isolates of
N. mcningitidiswere sus-
ceptible to the antibiotics
frequently used in its
treatment and prophylaxis.
Eighteen patients dieel
(R.9%). The time of death
rangeel between a fcw
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hours after admission to 22 days: S. pnclIfIloniacwas the
etiologic agent in six cases, StaphylococclIspp. in 4. N.mcningitidisi 3, S. pyogcncs.K. pncullloniacand E. coliin a patient ach. No agent was iele tified i the other twocases. D h o curreel aft r d y 14 in our of the cases (spnclI wniac n two, St phylococcuspp. a d K. p cum -niac in o e case each), as oci te lwith ute myo ardic
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Table 5
Unfavorable outcome and clínical and demographic variables.
Variables
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Systemiccomplications










*p < 0.05; alndifferent to i entification method
infarclion, pulmonary lhromboembolism, multiorgan
dysfunctionand nosocomialpneumoniaand inlracranial
hypertensionandcerebralinfarcl.SAPS II variedfrom 9





compared(Table 5). In a univarialeanalysis,age more
lhan 50years(aR 7.7;95°!c,CI 1.12-27.4),presenceof a
subjacentdisease(aR 3.3; 95% CI 1.1-9.6) and the
occurrenceof systemiccomplicalions(aR 5.8;95'}"0CI
2.1-16.0)wereassociatedwilh anadverseoutcome.When
we stratifiedlhis by agents,the neurologicaldysfunclion
wasslalislicallyassociatedwilh pooroulcomeinmeningitis
byN. mcningitidis(aR 64:95%CI 3.9-1034.3)andfor lhe
410
olher agentsno statisticalassocialionwasfound(5.pnell-
moniac:aR 0.54:95%CI 0.09-3.04;otheragenlsaR 0.40;
95%CI 0.04-3.8).A SAPS II valueabove30in lhefirst24 h
waspredictiveof death(aR 7.8:95% CI 2.2-26.4).
Discussion
This study includes201casesof bacterialmeningillsse-
lected in emergencydepartmentaccording 10 clinical
piclureandCSF study.Posteriordalawerecollectedfrom
medical recordsduring hospitalization,inducling some
limilalions in dataperformance.Anyway lhe mostcom-
mon symptomswere lhe classicones: fever, headache.
neck stiffnessand changein menlal status.We found
somedifferencesin c1inicalpresenlationby agegroupas
shownin table I. The sludy includedonly four neonales





beforediagnosis,bul only ten of thosehad negalivecul-
lures.A nonculturalidentificalioncan be due to several
factors mainly previous anlimicrobial lherapy and
including for CSF, lhe time lapse belween lhe lumbar
punclure and the smear of lhe samples.CSF requires
immediateprocessing,olherwisethe agenlswill die [22].
We think lhal lhis lasl point is relevant10 our hospilals
becauseit is frequentlhal samplesare collectedbut nol
immedialelyprocessed.
This enhancesthe impOrlanceof Gram-stainimme-
diatelyafterCSF collection,becauseit canbeveryhelpful
in empiricanlibiolic prescriptionwhenposilive.The same
waslrue for latexagglulinationlesl. a methodno longer
currentlyused,bul done ai lhe beginningof thestudyin
103of lhe samples.beingpositivein 65 assays.This lesl
alone definedthe aetiologyof lwo addilional cases,one
H. inflllenzaeandoneN. mcningitidis.In 59(29.4%) of lhe
casesno agenlcouldbe identifiedusingculturalmelhods.
Unfortunatelyit wasnol possible10 applyPCR assay
in ali negative culturesbecausesomesampleswere lost.
So. il was only possible10 apply the assayto 40 (68%)
negativeCSF cultureswilh anagentdefinitionin 33of the
samples:N. meningitidisin 17and S. pnellllloniaein 16.
The applicationof PCR 10 culture-confirmedCSF samples
of S.pncllllloniaeandN. IIlcningitidiswaspositivein ali of
the cases(100%).In lhe threecasesof I/. inflllenzaclhe
melhodfailedto detecttheagentin two,andalthoughthe
low numberof I/. injillcnzac strainsdoesnol allow any
conclusions,wethink thatfor fi. inflllenzacanothertarget
deleclingcapsulatedand non-capsulaledstrainsmustbe
sought[23.24]. If we considerculturelhe gold standard.
the sensilivilyof PCR for 5. pnellllloniaeand N. IIlcnin-
gitidis,was 100%(aR 95%: 85.9-100)for bolh of them
with a specificityof 77.8%and78.5%,respectively.PCR
madepossiblean agentdefinilion in aboulone quarterof
lhe casesof N. IIlcningitisandS. pnellllloniacmeningitis.
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With theconcurrentuseof ali theseelifferentmethoels.an
etiologicdiagnosiswas obtaineelin 177(XX°,.{,)casesof
meningitis.
Confirm<ltionof the etiologiceliagnosisis extn:mely
importantnot only for <I correcttreatment.butalso for a
continuousknowleelgeof epidemiologicalevolution of
meningitisagents.This canno longerbe baseeion c1assic
bacteriologicalmethoelsaneltheuseof realtimePCR anel
sybergreenc<lnbe a versatileaneleasyway to achievea
betterinsightinto thisseriousconclition.
In Portugal.as in other Europeancountries.N. II/cn-
il/gitis was previously the most common etiology of
meningitis,accountingfor about 55% of the casesin
ali age groups.followeelby S. pl/clI/nonillc (23'};,)anel
11. influcl/wc (12%) [251.In the presentstuely,S. pncu-
II/ol/iac was the most frequentagent.but with an inci-
elencesimilarto thatof N. II/cl/ingitidis. We identifieelfive
cases01'I/. influcnwc meningitis.but only two in 22-
month-olelanel2-year-olelchilelren,bothserotypeb. Both
chilelrenhaelbeen previouslyinoculatedwith the Hib
vaccineanelno immunosuppressiveconelitionwas ele-
tecteel.As previouslyobserveelin other stueliesS. pl/CU-
II/onillc is nowaelaysthe mostfrequentagent01'bacterial
meningitisanelthe meanageof incielencehasshiftedto-
warelaelultage[26].Seventy-eightpercentof thecasesof
meningitis by N. II/cnil/gitidis occurreel in children
younger than 15years anel 73.2% 01'S. pnculI/oniac
meningitisoccurreelin adults.
In thepresentstuelyantibioticsusceptibilitytestsfor
S.pnculI/o/Úac showeelthatali butsixof thestrains(11%)
weresusceptibleto penicillin.Thesestrainsare inc1udeel
in the mostcommonelrug-resistantserotypes[16.27J.
Although the incielence01'infectionsby S. pnculI/o-
niac resistantto penicillinanelother fi-Iaclamanlibiotics
variesgeographically.resistanceis increasingin Europe.
particularlyin France,Spainanelin theEastemEuropean




have been inclueleelin lhe immunizalionprograms01'
many Europeancountriesmore recently[30].This en-
hancesthe importanceof a correctepielemiologiclocal
knowledgeanelof a sustaineelsurveillance.namelyafter
vaccineintroduction.
Antigeniccharaclerizationof S. pnculI/ol/iac isolates
includedali age-groups.althoughwith the preelominance
01'adults(Table 3).Four out01'thesevenchilelrenyounger
than5 years01'agehadreceiveelthecommerciallyavail-
able7V-PnC vaccine.but thestrainsresponsiblefor their
meningitis,19A(n =2).6A and29.arenotinc1udedin this
vaeeine.The prevalcnceandserotypedistributionin our
investigationhasshownthat 14(43.8%)of the ielentitied
strainsare not inclueleelin the current formulation 01'
PPV23:68.8%arenot inc1udedin the7V-PnC anel62.5%
arenotpresentin the Ii V-PnC vaccines.whichis a lower
Infection 35 . 2007 . No. 6 © URBAN & VOGEl
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rate of eoveragethan that observeelin other European
stuelies.This partof thestudyis limitedandnotconclusive
as it wasonly possibleto defineserotypesin 32 (58%) 01'




the years1999anel2002.revealcelthat the potentialeov-
erage01'the7V-PnC vaeeinewouldbe a'.1out63'}loamong




As far asantigeniccharacterization01'N. II/cningitidi.l'
is coneerned.the more common phenotypeswere the
C:2b.pI.2.5and C:2b.pI.5.2.a elifferentresult from that
observeelnowadaysin lhe majority01'Europeancountries.
where the ineieleneeof phenotypeC:2a.P!.5 preelomi-
nates [32-34J. It was also interesting lhe finding 01'
W 135:2a:P1.5.2strainin threepalienls.thesameantigenie
combination founel in strains rclated to the Haj 2000
outbreak[35]andsporaelieallyfoundin Europe.Thus. in
spiteof theproximityof our metropolitanarea.situateelin
the north 01'Portugal.with European regionshavinga
elifferenlepidemiologiealpattem.lhe epidemiologiepat-
tem found in this study is still similar to whal was ob-
servedin the lastclecadein neighboringeountries.Now.
thatmeningoeoccalC conjugatedvaeeinehasbeenaddeel
to our immunization programme. it is important to
mainlain lhe surveillaneeto deleetan eventualantigenie
shift 01'N. II/cl/ingitidis phenotypes.
Aecorelingto guidelinespublishecl.dexamethasone
0.6mg/kg/elayin children and 15mg/elay-20mg/elayin
aelults.beginningeitherbeforeor simultaneouslywith the
first dose01'antibiotic.woulelbe recommeneleelin 14201'
the cases(in 71S. /J//culI/onillc. 69 N. II/cnil/gitidi.l' and in
two H. influcnwc). With ali the knowleelgeabout the
efficacy 01' elexamethasonein aeljuvanl treatment 01'





vant treatmentwith elexamethasonein aelultmeningitis.
themortalityin elexamethasonegroupwas7% vs 15%in
placebogroup [37].A recentreviewof randomizedcon-
trolled trials to examinethe eftieacyanelsafety01'adju-
vant corticosleroidtherapyin acutebaeterialmeningitis
showsa mortality01'13.4%vs 16.1% [38J.
The mortalityrate in our study(8.9%) anelthe faet
thatmorethan50% 01'the patientsfor whomdexameth-
asonewould be inelieateelhavenot eloneit. do not allow
for anyconclusionabouttheuse01'steroidsin our cohort.
Mortality rateasperour studywaslowerwhencompared
to olher elatafromthe lilerature.namelythemortality01'
S. pl/cUlI/ol/illc meningitis(8%). Traditionally.we havea
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lower mortalityrateof hacterialmeningitisthanthat re-
ferred [o in literatureand we cannotexplain [hisdiffer-
cnec.In a retrospectivestudywe earriedout someyears
ago,including3óópatients01' ali agegroups,admittedin
the ICU of our InfectiousDiseaseServicehetwccn1988
and 1997,48fatalitiesoccurred(13%) [391.
The univariatcstatisticalanalysisdone to evaluate
predietive factors associatedwith prognosis (Table 5)
showthatage,thepresence01' at leasta eomorbidityand
theoccurrenec01' systemiecomplicationswereassociated
with an adverseoutcome.Qnly in N. IIlcningifidis men-
ingitisneurologiealeomplieationswere statisticallyasso-
ciatedwi[ha highermortality.SAPS 11scorcat admission
wasalsopredictive01' a highrisk 01' death[40J.
A revision01' literaturestudiesabout the prognostic
factorsin meningitisrevealedthat the majorityof them
areretrospectiveusingdifferentvariables,whiehmakesit
difficult to compareconclusions.We found a Europcan
prospectivestudy01' van de I3cck et aI. [21 with theaim01'
evaluatingprognosticaspects,in whichthe authorshave
concludcdthat risk factorsfor an unfavorablcoutcome
wereassociatedwith theprcscnccof a systemiccompro-
mise,a low levcl of consciousnessand infection hy S.
fJncllllloniac. This studyalsohighlightsthehighmortality
elueto 01' meningitisin developcdcountries.
QUI' study included ali patients coming from the
communityaneladmittedin the emergencydcpartment
where the Manchestertriagc systemis now used and
infectiousdiseasesteamisealledlateron, if necessary.So,
thefrequentadministration01' antibioticsbeforediagnosis
01' meningitisin criticallyill patientswasa limitation,thus
impairingthe later recommendation01' corticostcroidsin
treatmentsupport.We areconsciousthat theapplication
01' [hisprotocolis elifficultto overcomein thissetting.
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